Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 31, 2019Responses to CAR-T Therapy in Multiple Myeloma - Sham Mailankody, MBBSNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies18 minPlay
December 31, 2019Dealing with Adverse Events and Toxicities in CAR-T cell Therapy - Deepu Madduri, MDNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies23 minPlay
December 31, 2019CAR-Ts: What are the Next-Gen Products and Strategies? - Adam D. Cohen, MDNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies22 minPlay
December 31, 2019Panel Discussion on CAR-T in Myeloma - James R. Berenson, MD; Sham Mailankody, MBBS; Deepu Madduri, MD; Adam D. Cohen, MDNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies8 minPlay
December 31, 2019Chemotherapy vs Novel Agents in Young CLL Patients: Is There Still a Role for Chemotherapy? - Neil E. Kay, MDFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy17 minPlay
December 31, 2019Novel Agents in Elderly CLL Patients: Should the Approach be Different? - Jennifer A Woyach, MDFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy21 minPlay
December 31, 2019Combination of Novel Agents: Is this the Final Answer? - John N. Allan, MDFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy25 minPlay
December 31, 2019Panel Discussion: Front-line CLL Treatment - Richard R. Furman, MD; Neil E. Kay, MD; Jennifer A. Woyach, MD; John N. Allan, MDFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy5 minPlay
December 31, 2019Venetoclax Resistance: Mechanisms and Treatment Options - Matthew S. Davids, MD, MMScFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy21 minPlay
December 31, 2019Update on CAR-T Cells in CLL - Thomas J. Kipps, MD, PhDFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy25 minPlay